Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | STK16 |
| Upstream (Parents) |
|---|
| (<<) BZW1 → STK16 |
| (<<) DVL1 → STK16 |
| (<<) HLA-G → STK16 |
| (<<) ITGB5 → STK16 |
| (<<) KCNJ2 → STK16 |
| (<<) MAP3K14 → STK16 |
| (<<) MKNK2 → STK16 |
| (<<) MPP1 → STK16 |
| (<<) PAK1 → STK16 |
| (<<) PDIA3 → STK16 |
| (<<) PKM2 → STK16 |
| (<<) RCOR1 → STK16 |
| (<<) RHOA → STK16 |
| (<<) RHOD → STK16 |
| (<<) RPL23A → STK16 |
| (<<) SLC29A1 → STK16 |
| (<<) SPDEF → STK16 |
| (<<) TINF2 → STK16 |
| (<<) TSG101 → STK16 |
| Downstream (Children) |
|---|
| STK16 → ADAM17 (>>) |
| STK16 → ARSD (>>) |
| STK16 → BCL6 (>>) |
| STK16 → BZW2 (>>) |
| STK16 → CXCL1 (>>) |
| STK16 → EFHD2 (>>) |
| STK16 → FZD1 (>>) |
| STK16 → MMP14 (>>) |
| STK16 → PPP2R5B (>>) |
| STK16 → PRKCG (>>) |
| STK16 → PSORS1C2 (>>) |
| STK16 → RDX (>>) |
